www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Microsoft Word - MD_A_Q3_2019_EN 1 GLOCON.061/2019 November 11th, 2019 Subject Management’s analysis for the 3rd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
No. CC20191103ELE November 12, 2019 Re: Clarification of the changes in operation performance for the third quarter and the nine- month period ended 30 September 2019 Attn: The President The Stock
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET
Page 1 of 2 AC6305/006 May 14, 2020 Subject Clarification of the operating results for the quarter 1/2020 ended March 31, 2020 To Director/ Managing Director The Stock Exchange of Thailand According
GUIDELINES FRC Investor Listing Standards Proposal: Recommendations for Stock Exchange CERES ผู้ประกอบวิชาชีพ/ Gatekeepe r เรื่อง หน่วยงาน Corporate Secretaries เลขานุการบริษัท CSIA แนวปฏิบัติการ
No. ACC6311/010 12 November, 2020 Subject Clarify the Operating results for quarter 3/2020 ended 30 September, 2020 Attention Director and Manager The Stock Exchange of Thailand According to Advanced